Single-crystalline KY 1-x-y-z Gd x Lu y Yb z (WO 4 ) 2 layers are grown onto undoped KY(WO 4 ) 2 substrates by liquid-phase epitaxy. The purpose of co-doping the KY(WO 4 ) 2 layer with suitable fractions of Gd 3? and Lu 3? is to achieve lattice-matched layers that allow us to engineer a high refractive-index contrast between waveguiding layer and substrate for obtaining tight optical mode confinement and simultaneously accommodate a large range of Yb 3? doping concentrations by replacing Lu 3? ions of similar ionic radius for a variety of optical amplifier or laser applications. Crack-free layers, up to a maximum lattice mismatch of *0.08 %, are grown with systematic variations of Y 3? , Gd 3? , Lu 3? , and Yb 3? concentrations, their refractive indices are measured at several wavelengths, and Sellmeier dispersion curves are derived. The influence of co-doping on the spectroscopy of Yb 3? is investigated. As evidenced by the experimental results, the lattice constants, refractive indices, and transition crosssections of Yb 3? in these co-doped layers can be approximated with good accuracy by weighted averages of data from the pure compounds. The obtained information is exploited to fabricate a twofold refractive-index-engineered sample consisting of a highly Yb 3? -doped tapered channel waveguide embedded in a passive planar waveguide, and a cladding-side-pumped channel waveguide laser is demonstrated.
Neodymium-doped aluminum oxide films with a range of Nd 3+ concentrations are deposited on silicon wafers by reactive co-sputtering, and single-mode channel waveguides with various lengths are fabricated by reactive ion etching. Photoluminescence at 880, 1060, and 1330 nm from the Nd 3+ ions with a lifetime of 325 µs is observed. Internal net gain at 845-945 nm, 1064, and 1330 nm is experimentally and theoretically investigated under continuous-wave excitation at 802 nm. Net optical gain of 6.3 dB/cm at 1064 nm and 1.93 dB/cm at 1330 nm is obtained in a 1.4-cm-long waveguide with a Nd 3+ concentration of 1.68 × 10 20 cm −3 when launching 45 mW of pump power. In longer waveguides a maximum gain of 14.4 dB and 5.1 dB is obtained at these wavelengths, respectively. Net optical gain is also observed in the range 865-930 nm and a peak gain of 1.57 dB/cm in a short and 3.0 dB in a 4.1-cm-long waveguide is obtained at 880 nm with a Nd 3+ concentration of 0.65 × 10 20 cm −3 . By use of a rate-equation model, the gain on these three transitions is calculated, and the macroscopic parameter of energy-transfer upconversion as a function of Nd 3+ concentration is derived. The high internal net gain indicates that Al 2 O 3 :Nd 3+ channel waveguide amplifiers are suitable for providing gain in many integrated optical devices.
Laser experiments were performed on buried, ridge-type channel waveguides in an 8 at. % thulium-doped, yttrium-gadolinium-lutetium codoped monoclinic double tungstate. A maximum slope efficiency of 70% and output powers up to 300 mW about 2.0 μm were obtained in a mirrorless laser resonator, by pumping with a Ti:sapphire laser near 800 nm. To the best of our knowledge, this result represents the most efficient 2 μm channel waveguide laser to date. Lasing is obtained at various wavelengths between 1810 nm and 2037 nm.
Laser experiments were performed on buried, ridge-type channel waveguides in 8 at.% thulium-doped, yttrium-gadolinium-lutetium co-doped potassium double tungstate. By pumping with a Ti:sapphire laser at 794 nm, 1.6 W of output power at 1.84 μm with a maximum slope efficiency of ∼80% was obtained in a laser resonator with a high output-coupling degree of 89%. To the best of our knowledge, this result represents the most efficient 2-μm channel waveguide laser to date.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.